Table of Contents
Acute tumour lysis syndrome
common oncological settings:
summary
complications:
management:
prognosis
Acute tumour lysis syndrome
see also
oncology
common oncological settings:
haematological malignancies (acute leukaemias & lymphomas)
summary
occurs within 1- 5 days of chemo/XRT of rapidly growing tumours that are extremely sensitive to treatment
in general, patients with solid tumours are not at risk
risk increased with:
large bulk of the tumour
hyperuricaemia - prior to Rx
renal impairment - prior to Rx
complications:
ARF (kidney provides 1° mech. for K+/uric acid/phosphate)
Integrity of renal Fx is critical in determining degree of metabolic derangements
cardiac dysrhythmias / sudden death ( hypocalcaemia, hyperkalaemia)
neuromuscular symptoms
hyperuricaemia
(DNA breakdown)
hyperkalaemia
(cytosol breakdown)
hyperphosphatemia
(protein breakdown)
hypocalcaemia
(2° to hyperphosphatemia)
management:
serum uric acid
U&E
serum calcium, phosphate
delay chemo/XRT until metabolic derangements are corrected
haemodialysis
if:
raised K+ ( ? if >6)
raised Uric acid ( ? if >59)
raised Cr ( ? if >0.9)
raised Phosphate ( ? if > 3.2)
volume overload
symptomatic hypocalcaemia
prognosis
good in absence of renal failure
if renal failure + hemodialysis is required > 5 days, prognosis is grave